Open AccessManagement of morning hypertension: a consensus statement of an Asian expert panel
Author(s) -
Wang JiGuang,
Kario Kazuomi,
Chen ChenHuan,
Park JeongBae,
Hoshide Satoshi,
Huo Yong,
Lee HaeYoung,
Li Yan,
Mogi Masaki,
Munakata Masanori,
Park Sungha,
Zhu Dingliang
Publication year - 2018
Publication title -
the journal of clinical hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 67
eISSN - 1751-7176
pISSN - 1524-6175
DOI - 10.1111/jch.13140
Subject(s) - morning , medicine , blood pressure , dosing , regimen , intensive care medicine , guideline , dose , pathology
Morning blood pressure (BP) surge is an important aspect of hypertension research. Morning BP monitoring could be a clinically relevant concept in the therapeutic management of hypertension and in the prevention of cardiovascular complications by defining and treating morning hypertension. Because antihypertensive medication is often taken in the morning, uncontrolled morning BP during the trough effect hours could be a hallmark of inadequate choice of antihypertensive regimen, such as the use of short‐ or intermediate‐acting drugs, underdosing of drugs, or no use or underuse of combination therapy. To improve the management of hypertension in general and morning hypertension in particular, long‐acting antihypertensive drugs should be used in appropriate, often full dosages and in proper combinations. The clinical usefulness of antihypertensive drugs with specific mechanisms for morning BP or split or timed dosing of long‐acting drugs in controlling morning BP remains under investigation.